BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6188185)

  • 1. Changes in alpha 1-antitrypsin (AAT) and alpha 2-macroglobulin serum concentrations during treatment with oral estro-progestogens.
    Paternoster D; Maggino T; Valente S; Pengo V; Ongaro G
    Quad Sclavo Diagn; 1982 Jun; 18(2):132-9. PubMed ID: 6188185
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of an estro-progestinic association in "sequential" treatment].
    Scaglione V; Arrotta U
    Attual Ostet Ginecol; 1968; 14(6):467-88. PubMed ID: 5738121
    [No Abstract]   [Full Text] [Related]  

  • 3. Individual levels of plasma alpha 2-antiplasmin and alpha 2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Sidelmann J
    Thromb Haemost; 1983 Aug; 50(2):581-5. PubMed ID: 6195752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice].
    Nalbanski B; Tsekova K; Ivanov S
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-Ovlon-Use in contraception and treatment of gynaecological affections(author's transl)].
    Dvorák K
    Cesk Gynekol; 1974 Nov; 39(9):716-8. PubMed ID: 4615825
    [No Abstract]   [Full Text] [Related]  

  • 7. The antiovulatory effect of ethinyl oestradiol in sequential therapy.
    Buus JG; Bang HO; Berthelsen HG
    Dan Med Bull; 1967 Jun; 14(7):161-4. PubMed ID: 6047306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Low dose p-pills, Gynatrol and Mikrogyn].
    Falck Larsen J
    Ugeskr Laeger; 1976 Sep; 138(40):2446-7. PubMed ID: 969002
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptives and thromboembolism.
    Med Lett Drugs Ther; 1972 Aug; 14(17):61-2. PubMed ID: 4567564
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of venous thrombosis varies with different types of combined oral contraceptives.
    DeSancho MT
    Evid Based Med; 2014 Apr; 19(2):e11. PubMed ID: 24288174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative clinical investigation of oral contraceptives with different doses (author's transl)].
    Mall-Haefeli M; Zodrow IW; Uettwiller A
    Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):553-7. PubMed ID: 467946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of changes in main serum proteinase inhibitors (alpha 1-antitrypsin and alpha 2-macroglobulin) in patients with pulmonary tuberculosis].
    Kaminskaia GO; Zhukova NL; Chukanov VI
    Probl Tuberk; 1983 Dec; (12):50-6. PubMed ID: 6198643
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing an oral contraceptive for the individual woman.
    Chick P
    Aust Fam Physician; 1980 Feb; Suppl():8-12. PubMed ID: 6444808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practitioner's dilemma.
    Jackson JL
    J Reprod Med; 1970 Jul; 5(1):36-7. PubMed ID: 5521769
    [No Abstract]   [Full Text] [Related]  

  • 16. [Individual administration of hormonal contraceptive agents, calculation of activity and corrective tendencies in adverse effects].
    Balmer JA
    Schweiz Rundsch Med Prax; 1972 Nov; 61(46):1406-17. PubMed ID: 4263804
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Review: Combined oral contraceptives are associated with venous thrombosis.
    Harper DM; Wilfling LE; Blanner CF
    Ann Intern Med; 2013 Dec; 159(12):JC12. PubMed ID: 24343405
    [No Abstract]   [Full Text] [Related]  

  • 18. [Description of a new method of ovarian inhibition: the "sequential method". Results of its use in the treatment of dysmenorrheas and inter-menstrual disorders. (Study of 172 subjects treated during 573 cycles)].
    Gueguen J
    Rev Fr Gynecol Obstet; 1967 Jun; 62(6):279-86. PubMed ID: 4193181
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alpha 1-antitrypsin, alpha 2-macroglobulin and reactive protein C in gastric cancer].
    Dumitraşcu D; Radu D; Stanciu L; Ioniţă A; Petcovici M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):57-61. PubMed ID: 2479968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of alpha1-antitrypsin and alpha2-macroglobulin in patients with acute and chronic pneumonia].
    Komar SI; Korobeĭnikova EN
    Vopr Med Khim; 1987; 33(4):46-9. PubMed ID: 2444032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.